Maastricht University Medical Centre+
Maastricht, Limburg, 6200MD, Netherlands
NCT Number: NCT01894737
The primary aim of this study is to determine the effect of creatine supplementation on muscle mass loss during short-term immobilisation in healthy, young people.
Looking for future studies?
Notify Me18 year–35 year
Male
Interventional
Not applicable
Maastricht, Limburg, 6200MD, Netherlands
Seven days of one-legged knee immobilisation in young subjects with creatine or Placebo supplementation. A randomly selected leg is immobilized for seven days. Muscle mass and strength will be determined and muscle biopsies will be collected before and immediately after immobilisation. A week after the cast is removed we will assess any differences in recovery between intervention groups.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Seven days of one-legged knee immobilisation with placebo supplementation
Seven days of one-legged knee immobilisation with creatine supplementation.
Time frame: Before and after 1 week of immobilisation, and after 1 week of recovery
immediately before and after 1 week of immobilisation, and after 1 week recovery, quadriceps CSA will be assessed
Time frame: Before and after 1 week of immobilisation, and after 1 week of recovery
immediately before and after 1 week of immobilization, and after 1 week of natural recovery
Time frame: before and after 1 week of immobilisation, and after 1 week of recovery
immediately before and after 1 week of immobilization, and after 1 week of natural recovery, one-repetition maximum (1RM) muscle strength will be assessed
Maastricht University Medical Center
Other
The Effect of Creatine Supplementation on Muscle Loss During Immobilisation
Acronym: CML
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05296096
Atrophy, Behavior
Baltimore, Maryland, United States
View Trial DetailsNCT06458530
Atrophy, Diabetes Mellitus
Durham, North Carolina, United States
View Trial DetailsNCT05927623
Aging, Atrophy
Calgary, Alberta, Canada
View Trial DetailsNCT06497426
Atrophy, Muscle Loss
Mataró, Barcelona, Spain
View Trial Details